Skip to main content
. 2017 Sep 28;12(9):e0185294. doi: 10.1371/journal.pone.0185294

Table 4. Factors associated with colorectal cancer mortality (N = 18,816).

Factors No. of deaths 1,000 person- years Crude HR P-value
Age category
 < 50 0 0 1
 50–59 0 0 NA NA
 60–69 0 0 NA NA
 70–79 2 0.123 NA NA
 ≥ 80 2 0.580 NA NA
Sex
 Female 2 0.105 1
 Male 2 0.042 0.41 (0.06–2.92) 0.374
Current smoker 0 0 NA NA
Family history of CRC 0 0 NA NA
Comorbidities
 Ischemic heart diseases 2 0.135 3.65 (0.51–25.9) 0.196
 Chronic heart failure 2 0.208 6.13 (0.86–43.6) 0.070
 Peripheral vascular diseases 2 0.290 9.59 (1.35–68.1) 0.024
 Cerebral vascular diseases 1 0.147 2.99 (0.31–28.7) 0.344
 Dementia 0 0 NA NA
 COPD 1 0.502 11.1 (1.15–106.5) 0.037
 Collagen diseases 0 0 NA NA
 Peptic ulcer diseases 3 0.094 3.39 (0.35–32.6) 0.291
 Diabetes mellitus 3 0.109 4.66 (0.48–44.8) 0.183
 Chronic kidney diseases 0 0 NA NA
 Paresthesia 0 0 NA NA
 Leukemia 0 0 NA NA
 Malignant lymphoma 0 0 NA NA
 Liver cirrhosis 0 0 NA NA
 AIDS 0 0 NA NA
Indication for colonoscopy
 Positive FIT 1 0.060 1.00 (0.10–9.60) 0.999
Initial colonoscopy findings
 Polyp detection 2 0.064 1.14 (0.16–8.07) 0.898
 10-mm adenoma detection 0 0 NA NA
 20-mm adenoma detection 0 0 NA NA
 Therapeutic colonoscopies 0 0 NA NA
Number of colonoscopies
 1 0 0 NA NA
 2 3 0.130 1
 3 1 0.106 1.60 (0.17–15.3) 0.686
 4 0 0 NA NA
 5 0 0 NA NA
 6 0 0 NA NA
 7 0 0 NA NA

The crude and adjusted hazard ratios of 10-mm and 20-mm adenoma detection were calculated using imputation data.

CRC, colorectal cancer; COPD, chronic pulmonary disease; AIDS, acquired immune deficiency syndrome; FIT, fecal immunochemical test; HR, hazard ratio; NA, not applicable.